Journal profile · Medicine-Oncology
Recent Results in Cancer Research
ISSN 0080-0015 · eISSN 2197-6767 · Springer Nature
FollowGet an email when its zone, impact factor or warning status changes
Recent Results in Cancer Research: fully open access; 13 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Recent Results in Cancer Research is published by Springer Nature. By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Lymphoma Diagnosis and Treatment and Breast Lesions and Carcinomas, together about 23.8% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
This book series presents comprehensive, high-quality updates on areas of current interest in basic, clinical, and translational cancer research. The scope of the series is broad, encompassing epidemiology, etiology, pathophysiology, prevention, diagnosis, and treatment. Each volume is devoted to a specific topic with the aim of providing readers with a thorough overview by acclaimed experts. While advances in understanding of the cellular, genetic, and molecular mechanisms of cancer and progress toward personalized cancer care are a particular focus, subjects such as the lifestyle, psychological, and social aspects of cancer and public policy are also covered. Recent Results in Cancer Research is accordingly of interest to a wide spectrum of researchers, clinicians, other health care professionals, and stakeholders.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology12%
- Lymphoma Diagnosis and TreatmentMedicine6%
- Breast Lesions and CarcinomasMedicine5.8%
- Immunotherapy and Immune ResponsesImmunology and Microbiology5.5%
- Viral-associated cancers and disordersMedicine4.5%
- Global Cancer Incidence and ScreeningMedicine4.3%
- Colorectal Cancer Treatments and StudiesMedicine4.1%
- Gastric Cancer Management and OutcomesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q3 | 308/428 | 28th |
| Cancer Research | Q4 | 197/233 | 15th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: INIS Atomindex, Norwegian Register for Scientific Journals and Series, Reaxys, SCImago
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 1,383OpenAlex ·
- 2-year mean citedness
- 0.77OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 3,623 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 30 | 0 | 715 |
| 2025 | 13 | 1 | 1,360 |
| 2024 | 0 | 0 | 1,597 |
| 2023 | 14 | 0 | 1,818 |
| 2022 | 0 | 0 | 1,869 |
| 2021 | 19 | 2 | 1,943 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Before you submit
Three checks before submitting to Recent Results in Cancer Research
- 1ScopeRecent output centres on Breast Cancer Treatment Studies, Lymphoma Diagnosis and Treatment.Check scope
- 2Article type and formatPrepare text, figures and references as the author guidelines ask.
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Springer Nature
- ISSN
- 0080-0015
- Electronic ISSN
- 2197-6767
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Recent Results in Cancer Research
Which databases index Recent Results in Cancer Research?
According to LetPub and DOAJ records, Recent Results in Cancer Research is indexed in Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Recent Results in Cancer Research open access, and what is the APC?
Recent Results in Cancer Research is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .